Alnylam Lays Out 2030 Vision, Bets On TTR Leadership And Pipeline Scale

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) announced a new five-year roadmap, "Alnylam 2030," on Sunday, outlining the company’s focus on scaling its operations.The strategy builds on the company's history of setting and meeting long-term goals, following the completion of its prior P5x25 plan. Management said Alnylam has met or exceeded all previous five-year objectives, setting the stage for its next phase of expansion.At the core of Alnylam 2030 is a push to establish durable global leadership in transth ...